Multiple endocrine neoplasia type 1 cost-effectiveness of therapy: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
Line 13: | Line 13: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Endocrinology]] | |||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} |
Revision as of 16:30, 21 July 2016
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 cost-effectiveness of therapy |
FDA on Multiple endocrine neoplasia type 1 cost-effectiveness of therapy |
CDC on Multiple endocrine neoplasia type 1 cost-effectiveness of therapy |
Multiple endocrine neoplasia type 1 cost-effectiveness of therapy in the news |
Blogs on Multiple endocrine neoplasia type 1 cost-effectiveness of therapy |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.